All good information and until a receipt of a positive outcome...

All good information and until a receipt of a positive outcome from study 7 the share price will have little to drive it. Also the stage 6 kit commercialisation is key to both the performance of the test in study 7, leading to reliable results, and also the ability to scale it's production up pending the signing of a possible contract if that eventuates. A lot going on that will essentially see RHY either rise quickly or fall very quickly to single cents.

I have noticed the usual volume games that get played out and at the moment the sell side is not wanting to see the price rise much with some very safe offers...it wouldn't surprise me if RHY will head to the 10% sophisticated investor cash pool to pull extra funds in during the first half of the year which will unfortunately dilute the holdings of others, however the reward will be significant if this does become something more substantial. Best of luck. I appreciate the contributions made by others.